{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:14:42Z","timestamp":1790856882265,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"4-5","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.plefa.2008.03.001","type":"journal-article","created":{"date-parts":[[2008,5,6]],"date-time":"2008-05-06T18:42:09Z","timestamp":1210099329000},"page":"257-263","source":"Crossref","is-referenced-by-count":20,"title":["Increased isoprostane content in coronary plaques obtained from vulnerable patients"],"prefix":"10.1016","volume":"78","author":[{"given":"A.","family":"Nishibe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Kijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Fukunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Nishiwaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Hata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.plefa.2008.03.001_bib1","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1161\/01.CIR.91.11.2844","article-title":"Molecular bases of the acute coronary syndromes","volume":"91","author":"Libby","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.plefa.2008.03.001_bib2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1136\/heart.84.1.93","article-title":"Coronary disease. Acute coronary syndromes: presentation\u2014clinical spectrum and management","volume":"84","author":"Fox","year":"2000","journal-title":"Heart"},{"key":"10.1016\/j.plefa.2008.03.001_bib3","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1161\/CIRCULATIONAHA.105.540013","article-title":"Detection and treatment of vulnerable plaques and vulnerable patients: novel approaches to prevention of coronary events","volume":"114","author":"Waxman","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.plefa.2008.03.001_bib4","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.plefa.2008.03.001_bib5","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0002-9440(10)64641-X","article-title":"Localization of apoptotic macrophages at the site of plaque rupture in sudden coronary death","volume":"157","author":"Kolodgie","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.plefa.2008.03.001_bib6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/01.STR.0000196986.50059.e0","volume":"37","author":"Sluijter","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.plefa.2008.03.001_bib7","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1161\/01.ATV.0000037101.40667.62","article-title":"Superoxide generation in directional coronary atherectomy specimens of patients with angina pectoris: important role of NAD(P)H oxidase","volume":"22","author":"Azumi","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.plefa.2008.03.001_bib8","doi-asserted-by":"crossref","first-page":"9383","DOI":"10.1073\/pnas.87.23.9383","article-title":"A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism","volume":"87","author":"Morrow","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.plefa.2008.03.001_bib9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1081\/DMR-100101910","article-title":"The isoprostanes: unique prostaglandin-like products of free-radical-initiated lipid peroxidation","volume":"31","author":"Morrow","year":"1999","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.plefa.2008.03.001_bib10","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1161\/01.ATV.17.11.2309","article-title":"Isoprostanes: potential markers of oxidant stress in atherothrombotic disease","volume":"17","author":"Patrono","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.plefa.2008.03.001_bib11","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1161\/01.CIR.0000116761.93647.30","article-title":"Urinary 8-iso-prostaglandin F2alpha as a risk marker in patients with coronary heart disease: a matched case\u2013control study","volume":"109","author":"Schwedhelm","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.plefa.2008.03.001_bib12","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1161\/01.CIR.80.2.410","article-title":"Unstable angina. A classification","volume":"80","author":"Braunwald","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.plefa.2008.03.001_bib13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1291\/hypres.25.91","article-title":"A role of oxidative stress-generated eicosanoid in the progression of arteriosclerosis in type 2 diabetes mellitus model rats","volume":"25","author":"Shinomiya","year":"2002","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.plefa.2008.03.001_bib14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1054\/plef.2001.0256","article-title":"Transcardiac 8-iso-prostaglandin F(2 alpha)generation from acute myocardial infarction heart: insight into abrupt reperfusion and oxidant stress","volume":"64","author":"Kijima","year":"2001","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.plefa.2008.03.001_bib15","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1253\/circj.71.1893","article-title":"Transient enhancement of oxidant stress and collagen turnover in patients with acute worsening of congestive heart failure","volume":"71","author":"Kunishige","year":"2007","journal-title":"Circ. J."},{"key":"10.1016\/j.plefa.2008.03.001_bib16","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1161\/01.ATV.17.11.3236","article-title":"Prostaglandin F2-like compounds, F2-isoprostanes are present in increased amounts in human atherosclerotic lesions","volume":"17","author":"Gniwotta","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.plefa.2008.03.001_bib17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1054\/plef.1998.0019","article-title":"6-Oxo-PGF1alpha and 8-epi-PGF 2alpha in human atherosclerotic vascular tissue","volume":"60","author":"Oguogho","year":"1999","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.plefa.2008.03.001_bib18","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1172\/JCI119735","article-title":"Localization of distinct F2-isoprostanes in human atherosclerotic lesions","volume":"100","author":"Pratico","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.plefa.2008.03.001_bib19","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1172\/JCI3985","article-title":"The relationship of hydroxyeicosatetraenoic acids and F2-isoprostanes to plaque instability in human carotid atherosclerosis","volume":"103","author":"Mallat","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.plefa.2008.03.001_bib20","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0008-6363(99)00108-X","article-title":"The isoprostane, 8-epi-PGF2 alpha, is accumulated in coronary arteries isolated from patients with coronary heart disease","volume":"43","author":"Mehrabi","year":"1999","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.plefa.2008.03.001_bib21","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1161\/01.CIR.96.10.3314","article-title":"Increased formation of the isoprostanes IPF2alpha-I and 8-epi-prostaglandin F2 alpha in acute coronary angioplasty: evidence for oxidant stress during coronary reperfusion in humans","volume":"96","author":"Reilly","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.plefa.2008.03.001_bib22","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1161\/01.CIR.95.11.2492","article-title":"8-epi PGF2 alpha generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo","volume":"95","author":"Delanty","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.plefa.2008.03.001_bib23","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0735-1097(01)01135-4","article-title":"Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction: an angioscopic study","volume":"37","author":"Asakura","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.plefa.2008.03.001_bib24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00380-005-0833-9","article-title":"Effects of atorvastatin on inflammation and oxidative stress","volume":"20","author":"Sugiyama","year":"2005","journal-title":"Heart Vessels"},{"key":"10.1016\/j.plefa.2008.03.001_bib25","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1161\/01.CIR.0000038500.43292.D7","article-title":"Low-density lipoprotein level reduction by the 3-hydroxy-3-methylglutaryl coenzyme-A inhibitor simvastatin is accompanied by a related reduction of F2-isoprostane formation in hypercholesterolemic subjects: no further effect of vitamin E","volume":"106","author":"De Caterina","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.plefa.2008.03.001_bib26","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0891-5849(03)00395-2","article-title":"Acute angiotensin II increases plasma F2-isoprostanes in salt-replete human hypertensives","volume":"35","author":"Murphey","year":"2003","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.plefa.2008.03.001_bib27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1161\/01.CIR.51.4.5","article-title":"A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association","volume":"51","author":"Austen","year":"1975","journal-title":"Circulation"}],"container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095232780800029X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095232780800029X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,29]],"date-time":"2018-12-29T00:54:43Z","timestamp":1546044883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095232780800029X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":27,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S095232780800029X"],"URL":"https:\/\/doi.org\/10.1016\/j.plefa.2008.03.001","relation":{},"ISSN":["0952-3278"],"issn-type":[{"value":"0952-3278","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}